Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 17, 2019

DrugPatentWatch Database Preview

Pfizer Ireland Company Profile

« Back to Dashboard

What is the competitive landscape for PFIZER IRELAND, and what generic and branded alternatives to PFIZER IRELAND drugs are available?

PFIZER IRELAND has one approved drug.

Summary for Pfizer Ireland

US Patents:	0
Tradenames:	1
Ingredients:	1
NDAs:	1
Patent Litigation for Pfizer Ireland:	See patent lawsuits for Pfizer Ireland

Drugs and US Patents for Pfizer Ireland

+ Get email alerts for changes to this table

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer Ireland	RELPAX	eletriptan hydrobromide	TABLET;ORAL	021016-002	Dec 26, 2002	AB	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Pfizer Ireland	RELPAX	eletriptan hydrobromide	TABLET;ORAL	021016-001	Dec 26, 2002	AB	RX	Yes	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Pfizer Ireland

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer Ireland	RELPAX	eletriptan hydrobromide	TABLET;ORAL	021016-002	Dec 26, 2002	6,110,940	➤ Sign Up
Pfizer Ireland	RELPAX	eletriptan hydrobromide	TABLET;ORAL	021016-001	Dec 26, 2002	5,545,644	➤ Sign Up
Pfizer Ireland	RELPAX	eletriptan hydrobromide	TABLET;ORAL	021016-002	Dec 26, 2002	5,545,644	➤ Sign Up
Pfizer Ireland	RELPAX	eletriptan hydrobromide	TABLET;ORAL	021016-001	Dec 26, 2002	6,110,940	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for PFIZER IRELAND drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	20 mg and 40 mg	➤ Subscribe	2010-03-29

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.